Recurrent Esophageal Adenocarcinoma
specificThe reemergence of esophageal adenocarcinoma after a period of remission.
15
Centers
15
Active Trials
—
Cancer Funding
Top Centers for Recurrent Esophageal Adenocarcinoma(15)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 53.3 |
| 2 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 53.3 |
| 3 | NCI Comprehensive Active Research Program | 53.3 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 53.3 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 53.3 |
| 6 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 53.3 |
| 7 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 53.3 |
| 8 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 53.3 |
| 9 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 53.3 |
| 10 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 53.3 |
| 11 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.3 |
| 12 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 53.3 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 53.3 |
| 14 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 53.3 |
| 15 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 53.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →